Telehealth Multi-Component Optional Model (MOM) Study
Comparative Evaluation of Telehealth Multi-Component Optional Model (MOM) of Postpartum Care Among Rural, Low-income, and Diverse Women
1 other identifier
interventional
1,500
1 country
6
Brief Summary
The aim of this study is to conduct a comparative effectiveness evaluation using a randomized control trail design among diverse women to compare two postpartum care models: 1) Telehealth Multicomponent Optimal Model (Telehealth MOM) and 2) enhanced standard of care (ESoC). This study will address critical gaps in knowledge about how best to deliver comprehensive postpartum care that ensures timely identification and treatment of complications and meets the needs and preferences of diverse patients, including disproportionately-impacted racial groups and rural residents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2024
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2023
CompletedFirst Posted
Study publicly available on registry
October 23, 2023
CompletedStudy Start
First participant enrolled
February 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 5, 2026
February 1, 2026
3 years
October 17, 2023
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Completion of post-partum 6-week comprehensive visit
Binary measure (yes/no) of visit completion
Baseline to 6 weeks post-partum
Study Arms (2)
Telehealth MOM
EXPERIMENTALTelehealth MOM. Each patient will receive ESoC which includes: education on the symptoms to watch for and when to call their healthcare provider, an in-person comprehensive postpartum visit around 6 weeks postpartum, and any additional care deemed necessary by their health care providers. Patients in the Telehealth MOM arm will be also provided with a remote monitoring blood pressure cuff and thermometer and will be instructed to take their blood pressure and temperature twice a day for 14 days after discharge from the hospital. A Registered Nurse will monitor blood pressure and temperature readings over the 14-day period and will contact the patient if the readings are out of range to discuss symptoms and the recommend a course of action. A Registered Nurse will conduct an early postpartum telehealth visit between 10-14 days postpartum.
Enhanced Standard of Care
ACTIVE COMPARATOREnhanced standard of care (ESoC). Each patient will be provided education on the symptoms to watch for and when to call their healthcare provider. Patients will be scheduled for a comprehensive postpartum visit around 6 weeks postpartum and any additional care deemed necessary by their health care providers.
Interventions
Patients will receive enhanced standard of care which includes: education on symptoms and when to call their healthcare provider, comprehensive 6-week post-partum visit, and any healthcare deemed necessary by providers.
Patients will receive enhanced standard of care plus remote blood pressure monitoring, remote thermometer, and a 10- to 14-day post-partum telehealth visit.
Eligibility Criteria
You may qualify if:
- Pregnant women between 16-35 weeks gestation
- Age 18-44 years
- Ability to speak English, Spanish, or Marshallese
- Participants may have either a vaginal birth or cesarean section birth
You may not qualify if:
- Type 1 diabetes on an insulin pump followed closely by endocrinology
- Uncontrolled Type 2 diabetes
- End stage renal disease followed closely by nephrology
- ICU admission at any point during pregnancy or delivery hospitalization
- Other maternal conditions requiring additional surgeries (i.e. cesarean hysterectomy or intrapartum or postpartum oophorectomy/appendectomy)
- Incarceration
- Mental disability limiting decision-making capacity
- Uncontrolled chronic hypertension
- HELLP syndrome during pregnancy
- Sickle cell disease
- Maternal heart condition or heart disease
- Opioid use disorder
- Lupus
- Thrombophilia or blood clots
- Need for blood transfusion during delivery hospitalization
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
UAMS El Dorado FMC
El Dorado, Arkansas, 71730, United States
UAMS Fayetteville FMC
Fayetteville, Arkansas, 72703, United States
UAMS Fort Smith FMC
Fort Smith, Arkansas, 72901, United States
UAMS Jonesboro FMC
Jonesboro, Arkansas, 72401, United States
UAMS Health Women's Center
Little Rock, Arkansas, 72205, United States
UAMS Springdale FMC
Springdale, Arkansas, 72764, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Callaghan-Koru, PhD
University of Arkansas
- PRINCIPAL INVESTIGATOR
Pearl McElfish, PhD
University of Arkansas
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2023
First Posted
October 23, 2023
Study Start
February 12, 2024
Primary Completion (Estimated)
January 30, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share